IL83687A0 - - Google Patents

Info

Publication number
IL83687A0
IL83687A0 IL83687A IL8368787A IL83687A0 IL 83687 A0 IL83687 A0 IL 83687A0 IL 83687 A IL83687 A IL 83687A IL 8368787 A IL8368787 A IL 8368787A IL 83687 A0 IL83687 A0 IL 83687A0
Authority
IL
Israel
Prior art keywords
receptor
pct
decoyant
retains
sec
Prior art date
Application number
IL83687A
Other languages
English (en)
Other versions
IL83687A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IL8368787A priority Critical patent/IL83687A/en
Publication of IL83687A0 publication Critical patent/IL83687A0/xx
Priority to AU23839/88A priority patent/AU2383988A/en
Priority to EP88908569A priority patent/EP0329778B1/en
Priority to JP63507516A priority patent/JP2791074B2/ja
Priority to AT88908569T priority patent/ATE123224T1/de
Priority to US07/410,778 priority patent/US5770572A/en
Priority to CA000576111A priority patent/CA1336489C/en
Priority to PCT/US1988/002991 priority patent/WO1989001779A1/en
Priority to DE3853910T priority patent/DE3853910T2/de
Priority to FI892005A priority patent/FI100169B/fi
Priority to NO89891787A priority patent/NO891787L/no
Priority to DK198902119A priority patent/DK175596B1/da
Publication of IL83687A publication Critical patent/IL83687A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polyamides (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paper (AREA)
  • Battery Electrode And Active Subsutance (AREA)
IL8368787A 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions IL83687A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
DE3853910T DE3853910T2 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung.
AT88908569T ATE123224T1 (de) 1987-08-30 1988-08-30 Molekulare köder und deren verwendung.
EP88908569A EP0329778B1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
JP63507516A JP2791074B2 (ja) 1987-08-30 1988-08-30 分子状デコイアント及びその使用方法
AU23839/88A AU2383988A (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
US07/410,778 US5770572A (en) 1987-08-30 1988-08-30 Methods and compositions using molecular decoyants for ameliorating the undesired effects of foreign agents which bind to endogenous receptors
CA000576111A CA1336489C (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
PCT/US1988/002991 WO1989001779A1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
FI892005A FI100169B (fi) 1987-08-30 1989-04-27 Menetelmä molekulaarisen syötin valmistamiseksi
NO89891787A NO891787L (no) 1987-08-30 1989-04-28 Molekylaere lokkemidler og fremgangsmaate for anvendelse derav.
DK198902119A DK175596B1 (da) 1987-08-30 1989-05-01 Molekylfælde og anvendelse deraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions

Publications (2)

Publication Number Publication Date
IL83687A0 true IL83687A0 (https=) 1988-01-31
IL83687A IL83687A (en) 1995-03-30

Family

ID=11058121

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions

Country Status (12)

Country Link
US (1) US5770572A (https=)
EP (1) EP0329778B1 (https=)
JP (1) JP2791074B2 (https=)
AT (1) ATE123224T1 (https=)
AU (1) AU2383988A (https=)
CA (1) CA1336489C (https=)
DE (1) DE3853910T2 (https=)
DK (1) DK175596B1 (https=)
FI (1) FI100169B (https=)
IL (1) IL83687A (https=)
NO (1) NO891787L (https=)
WO (1) WO1989001779A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02501192A (ja) * 1987-09-04 1990-04-26 バイオジェン インコーポレイテッド 可溶性ｔ４蛋白を製造するためのｄｎａ配列、組換ｄｎａ分子および方法
US5132402A (en) * 1987-11-25 1992-07-21 Agency Of Industrial Science And Technology Adsorbent, method for production thereof, and method for use thereof
EP0318240A3 (en) * 1987-11-25 1990-08-16 AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY Peptide, adsorbent, method for production thereof, and method for use thereof
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
US8535672B2 (en) * 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
RU2005102604A (ru) * 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
JP4495776B1 (ja) * 2009-07-30 2010-07-07 日本製薬株式会社 融合蛋白質
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2015153647A1 (en) * 2014-03-31 2015-10-08 Mice With Horns, Llc Method of preventing or reducing virus transmission in animals
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US5126433A (en) * 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4
DE3751751T2 (de) * 1986-08-21 1996-10-17 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids

Also Published As

Publication number Publication date
JP2791074B2 (ja) 1998-08-27
DK175596B1 (da) 2004-12-13
EP0329778B1 (en) 1995-05-31
FI100169B (fi) 1997-10-15
US5770572A (en) 1998-06-23
IL83687A (en) 1995-03-30
WO1989001779A1 (en) 1989-03-09
EP0329778A1 (en) 1989-08-30
JPH02502538A (ja) 1990-08-16
FI892005A0 (fi) 1989-04-27
CA1336489C (en) 1995-08-01
DK211989D0 (da) 1989-05-01
NO891787L (no) 1989-06-06
DE3853910D1 (de) 1995-07-06
AU2383988A (en) 1989-03-31
EP0329778A4 (en) 1990-12-27
FI892005L (fi) 1989-04-27
DK211989A (da) 1989-06-28
ATE123224T1 (de) 1995-06-15
DE3853910T2 (de) 1995-10-12
NO891787D0 (no) 1989-04-28

Similar Documents

Publication Publication Date Title
IL83687A0 (https=)
PT781129E (pt) Preparacao farmaceutica contendo metformina e processo para a sua preparacao
BR9408377A (pt) Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
PT86399A (pt) Processo para a preparacao de hidrossoles de agentes farmacologicamente activos e de composicoes que os contem
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
EP0175583A3 (en) Sanitant arrangement
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
NO834340L (no) Nye polypeptider
EP0173092A3 (en) Anti viral composition
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
AU2626488A (en) 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction
MX14957A (es) Nuevos derivados de tetrazol y procedimiento para su preparacion.
PT94625A (pt) Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
PT89659A (pt) Processo para a preparacao de {(5(6) (1h-azole-1-ilmetil)benzimidazole}-carbamatos e de composicoes farmaceuticas que os contem
ES2058992T3 (es) Un procedimiento para la preparacion de polipeptido que estimula celulas t.
BR9808424A (pt) Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto.
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
DE3686706D1 (de) Glaukomhemmende zusammensetzungen und verfahren zu ihrer herstellung.
IT1157268B (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired